• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: K2M, INC. CONSTRAINED PLATE, 4 LEVEL; SIZE 85 MM; APPLIANCE, FIXATION, SPINAL INTERVERTEBRAL BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

K2M, INC. CONSTRAINED PLATE, 4 LEVEL; SIZE 85 MM; APPLIANCE, FIXATION, SPINAL INTERVERTEBRAL BODY Back to Search Results
Model Number 208-44F85
Medical Device Problem Code Fracture (1260)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/13/2022
Type of Reportable Event Serious Injury
Event or Problem Description
A physician reported that a patient underwent revision surgery to address a fractured four-level constrained pyrenees plate.
 
Additional Manufacturer Narrative
Visual inspection confirms the plate is fractured across the middle plate screw holes.The plate is visibly worn, most likely from normal wear and in vivo conditions for eight-months.Device history records were reviewed and no relevant manufacturing issues were identified.Complaint history was reviewed and no similar complaints for the reported lot number were identified.Device stg reviewed: the patient must be made aware of the limitations of the implant and that physical activity and load bearing have been implicated in premature loosening, bending or fracture of internal fixation devices.The patient should understand that an implant is not as strong as a normal, healthy bone and will fracture under normal load bearing in the absence of complete bone healing.An active, debilitated or uncooperative patient who cannot properly restrict activities may be at particular risk during postoperative rehabilitation.Potential risks identified with the use of this device system which may require additional surgery include device component failure, loss of fixation, non-union, fracture of the vertebra, and neurological, vascular or visceral injury.The implants are intended to provide temporary stabilization.If an implant remains implanted after complete healing it can actually increase the risk of refracture in an active individual.The surgeon should weigh the risks versus the benefits when deciding whether to remove the implant.Internal fixation devices are load sharing devices which maintain alignment until healing occurs.If healing is delayed or does not occur the implant could eventually break, bend or loosen.Loads produced by load bearing and activity levels will impact the longevity of the implant.Implants can loosen, fracture, corrode, migrate, cause pain, or stress shield bone ven after a bone has healed.If an implant remains implanted after complete healing, it can actually increase the risk of refracture in an active individual.The surgeon should weigh the risks versus benefits when deciding whether to remove the implant.Implant removal should be followed by adequate postoperative management to avoid refracture.Limited information regarding the event was made available to stryker.Multiple attempts were made to obtain additional information, but no response was received.A root cause cannot be established.If additional information is received or the device is returned for evaluation, the investigation will be reopened and updated.
 
Event or Problem Description
A physician reported that a patient underwent revision surgery to address a fractured four-level constrained pyrenees plate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSTRAINED PLATE, 4 LEVEL; SIZE 85 MM
Common Device Name
APPLIANCE, FIXATION, SPINAL INTERVERTEBRAL BODY
Manufacturer (Section D)
K2M, INC.
600 hope parkway se
leesburg VA 20175
Manufacturer (Section G)
K2M, INC.
600 hope parkway se
leesburg VA 20175
Manufacturer Contact
rita karan
2 pearl court
allendale, NJ 07401
2017608000
MDR Report Key13361709
Report Number3004774118-2022-00029
Device Sequence Number1778455
Product Code KWQ
UDI-Device Identifier10888857031401
UDI-Public10888857031401
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K063544
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2022
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number208-44F85
Device Catalogue Number208-44F85
Device Lot NumberDLTM
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/13/2022
Supplement Date Received by Manufacturer04/12/2022
Initial Report FDA Received Date01/26/2022
Supplement Report FDA Received Date05/10/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/17/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age68 YR
Patient SexMale
-
-